Histone deacetylase inhibitor CG200745 ameliorates high-fat diet-induced hypertension via inhibition of angiotensin II production

Obesity is growing rapidly worldwide due to consumption of westernized diet and lack of exercise. Obesity is one of the major risk factors of hypertension. The novel histone deacetylase (HDAC) inhibitor CG200745 was originally developed to treat various cancers. Previous studies showed that CG200745...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Naunyn Schmiedebergs Arch Pharmacol
Asıl Yazarlar: Yoon, Ga-Eun, Jung, Jin Ki, Lee, Yun-Han, Jang, Byeong-Churl, In Kim, Jee
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7280340/
https://ncbi.nlm.nih.gov/pubmed/31655853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00210-019-01749-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller